Hepatitis C, ChronicHepacivirusRibavirinGenotypePolyethylene GlycolsInterferon-alphaAntiviral AgentsHepatitis CRNA, ViralDrug Therapy, CombinationRecombinant ProteinsHepatitis C AntibodiesViral Nonstructural ProteinsViral LoadLiver CirrhosisHepatitis C AntigensEgyptViral Core ProteinsAlanine TransaminaseCryoglobulinemiaInterferonsCoinfectionRepliconMolecular Sequence DataViral Hepatitis VaccinesTreatment OutcomePolymerase Chain ReactionLiverAntigens, CD815' Untranslated RegionsInterleukinsPakistanPhylogenyPolymorphism, Single NucleotideDrug Resistance, ViralSequence Analysis, DNABiopsyVirus ReplicationHIV InfectionsSubstance Abuse, IntravenousPrevalenceHepatocytesGenetic VariationPolymorphism, GeneticViremiaBase SequenceMoldovaViral Envelope ProteinsBlood DonorsReverse Transcriptase Polymerase Chain ReactionCohort StudiesRisk FactorsCarcinoma, HepatocellularHepatitis BAllelesReagent Kits, DiagnosticUridine MonophosphateHepatitis AntibodiesOligopeptidesCase-Control StudiesPolymorphism, Restriction Fragment LengthFatty LiverDNA, ViralMolecular EpidemiologyRecurrenceGenome, ViralProspective StudiesRetrospective StudiesRomaniaProtease InhibitorsMutationDisease ProgressionAmino Acid SequenceLiver NeoplasmsGene FrequencyLiver TransplantationRemission, SpontaneousGenetic Predisposition to DiseaseTime FactorsHepatitis, ChronicEnzyme-Linked Immunosorbent AssayProgrammed Cell Death 1 ReceptorMacrocyclic CompoundsVirologyBrazilRenal DialysisLogistic ModelsLeukocytes, MononuclearBiological MarkersHemophilia ACell LineSeverity of Illness IndexChinaChronic DiseaseSerine Proteinase InhibitorsPan troglodytesMolecular TypingItalySensitivity and SpecificityCell Line, Tumor